| Cluey Ltd (CLU) ORDINARY FULLY PAID |
Consumer Discretionary |
$4 |
Cluey achieves first quarterly positive cash flow result
|
31 Jul 2025 9:09AM |
$0.080 |
$0.010 |
fallen by
87.50%
|
|
CLU - Price-sensitive ASX Announcement
Full Release
Key Points
- Cluey Ltd achieved its first ever positive quarterly operating cash flow in Q1 FY24.
- Group receipts from customers were $10.8 million and operating cash flow was $0.2 million.
- Group revenue increased by 14% year-on-year, reaching $10.7 million.
- Contribution Margin for the Group improved to 52% from 47% in the prior corresponding period.
- Cluey ended the quarter with $9.1 million in cash and no debt.
- Strong customer retention and improved marketing efficiency contributed to the positive results.
- Cost reductions and operational efficiencies were key drivers of improved performance.
- Cluey Learning, Code Camp, and Cluey Schools divisions all contributed to growth.
- Strategic focus remains on sustainable profitability through continued revenue growth and disciplined cost management.
- Management expects to maintain positive cash flow in future periods based on current performance and initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MoneyMe Limited (MME) ORDINARY FULLY PAID |
Financials |
$68 |
4Q25 Trading Update - Strong growth and credit performance
|
31 Jul 2025 9:09AM |
$0.138 |
$0.084 |
fallen by
38.91%
|
|
MME - Price-sensitive ASX Announcement
Full Release
Key Points
- Record quarterly loan originations, demonstrating robust demand and market share gains.
- Continued improvement in credit performance, with lower arrears and net losses.
- Growth in the customer base and enhanced digital customer experience.
- Cost management initiatives leading to improved operational efficiencies.
- Diversification of funding sources and reduction in funding costs.
- Strong balance sheet position with prudent capital management.
- Positive outlook for further scaling and profitability supported by technology and innovation.
- Ongoing focus on sustainable, technology-driven lending solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$20 |
Quarterly Activities Report June 2025
|
31 Jul 2025 9:09AM |
$0.011 |
$0.010 |
fallen by
13.64%
|
|
LIT - Price-sensitive ASX Announcement
Full Release
Key Points
- LIT focused on advancing its lithium battery recycling business (Envirostream), lithium chemicals production through the LieNA® process, and technology development.
- Envirostream increased its battery collection volumes during the quarter, with continued expansion in its collection network and improving processing efficiencies.
- LieNA® pilot plant operations advanced, with the aim of demonstrating continuous production of high-purity lithium chemicals suitable for the battery industry.
- The company made progress in securing regulatory approvals and developing partnerships with industry and government for battery recycling.
- Livium Ltd, a subsidiary, continued to develop and validate its lithium ferro phosphate (LFP) cathode production technology.
- LIT participated in government and industry initiatives to support the circular battery economy and regulatory compliance for battery recycling.
- Financially, LIT maintained prudent expenditure, with a cash position that supports ongoing development activities.
- Future priorities include scaling Envirostream operations, progressing LieNA® commercialisation, and seeking further industry partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Core Energy Minerals Ltd (CR3) ORDINARY FULLY PAID |
Materials |
$7 |
Update on New Convertible Notes
|
31 Jul 2025 9:08AM |
$0.014 |
$0.010 |
fallen by
28.57%
|
|
| Dotz Nano Limited (DTZ) ORDINARY FULLY PAID |
Information Technology |
$32 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:08AM |
$0.040 |
$0.046 |
risen by
15%
|
|
DTZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Released Appendix 4C Quarterly Activities and Cash Flow Report for Q1 2023
- Reported advancements in anti-counterfeit, tracing, and diagnostics technologies
- Highlighted commercial agreements and development of DotzMed and DotzProtect platforms
- Continued focus on commercialisation and expansion of sales channels
- Engaged with both new and existing partners for further business opportunities
- Detailed operating cash flows, investments, and cash balance
- Demonstrated prudent financial management to support ongoing operations and growth initiatives
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$7 |
Trading Halt
|
31 Jul 2025 9:08AM |
$0.015 |
$0.014 |
fallen by
6.67%
|
|
IBX - Price-sensitive ASX Announcement
Full Release
Key Points
- Imagion Biosystems Limited (IBX) requested a trading halt on 10 July 2023.
- The trading halt is related to an upcoming capital raising announcement.
- Trading will resume either on 12 July 2023 or when the announcement is made.
- The halt ensures an orderly market under ASX Listing Rule 17.1.
- The company aims to prevent trading on an uninformed basis during this period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brightstar Resources Limited (BTR) ORDINARY FULLY PAID |
Materials |
$412 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:08AM |
$0.455 |
$0.375 |
fallen by
17.58%
|
|
BTR - Price-sensitive ASX Announcement
Full Release
Key Points
- Brightstar Resources Limited reported on activities for the quarter ended 31 December 2023.
- Significant progress achieved at the Laverton and Menzies Gold Projects with successful drilling programs resulting in resource growth.
- Completed an oversubscribed $5 million capital raising to fund exploration and development activities.
- Updated resources for Cork Tree Well and Link projects were published, increasing confidence and scale of the projects.
- Technical studies including scoping and feasibility studies commenced for the Laverton Gold Project.
- Closing cash balance of $5.9 million as of 31 December 2023.
- Focus remains on advancing technical studies, further drilling, and resource updates to support a restart of gold production.
- Ongoing engagement with stakeholders and investors to communicate progress and value creation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FINEOS Corporation Holdings PLC (FCL) CHESS DEPOSITARY INTERESTS 1:1 |
Information Technology |
$897 |
HY25 Result Release Date and Conference Call Details
|
31 Jul 2025 9:07AM |
$2.780 |
$2.600 |
fallen by
6.47%
|
|
| Blue Star Helium Limited (BNL) ORDINARY FULLY PAID |
Energy |
$38 |
Proposed issue of securities - BNL
|
31 Jul 2025 9:07AM |
$0.006 |
$0.007 |
risen by
16.67%
|
|
| Blue Star Helium Limited (BNL) ORDINARY FULLY PAID |
Energy |
$38 |
Placement to Raise A$4.5 Million
|
31 Jul 2025 9:07AM |
$0.006 |
$0.007 |
risen by
16.67%
|
|
BNL - Price-sensitive ASX Announcement
Full Release
Key Points
- Blue Star Helium Limited raises A$4.5 million via placement to institutional, sophisticated, and professional investors.
- Proceeds to fund drilling and development at Voyager helium project in Colorado, as well as working capital and corporate costs.
- Strong support for placement; directors intend to participate subject to shareholder approval.
- Issue price represents a discount to the 5-day volume weighted average price.
- Share Purchase Plan (SPP) to follow for eligible shareholders, aiming to raise up to A$1.5 million.
- Funds will support operational milestones and business development objectives.
- Placement does not require shareholder approval due to available placement capacity.
- The SPP record date and timetable are specified in the announcement.
- Board views the funds raised as critical for near-term growth and execution of strategic objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| American Rare Earths Limited (ARR) ORDINARY FULLY PAID |
Materials |
$230 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:07AM |
$0.320 |
$0.400 |
risen by
25%
|
|
ARR - Price-sensitive ASX Announcement
Full Release
Key Points
- Upgraded JORC Resource at Halleck Creek Rare Earth Project to 2.34 billion tonnes at 3,196 ppm TREO.
- Positive preliminary metallurgical test work supports development pathway.
- Scoping Study for Halleck Creek well underway, progressing toward completion.
- Released inaugural Environmental, Social & Governance (ESG) report.
- Completed further drilling and resource definition activities at Halleck Creek.
- Ongoing exploration at the Cowboy State Mine and other Wyoming prospects.
- Appointed new Chief Financial Officer and strengthened management team.
- Quarterly net cash used in operating activities was approximately $2.6 million.
- Cash and cash equivalents at period end were $10.3 million.
- Exploration and evaluation expenditure for the quarter totaled $2.0 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$50 |
Jun 25 Quarterly Activities Report and Appendix 4C
|
31 Jul 2025 9:07AM |
$0.056 |
$0.140 |
risen by
150%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report covers operational and financial updates for Rhythm Biosciences Limited.
- ColoSTAT® commercialization and regulatory progress, including CE Mark submission.
- Ongoing activities and strategies for market expansion in Australia, UK, and Europe.
- Key appointments and management commentary on operational progress.
- Financial disclosure includes operating cash outflows and end-of-period cash balance.
- Focus on expenditure, anticipated business milestones, and company funding position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cosmo Metals Limited (CMO) ORDINARY FULLY PAID |
Materials |
$7 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:07AM |
$0.019 |
$0.010 |
fallen by
47.37%
|
|
CMO - Price-sensitive ASX Announcement
Full Release
Key Points
- Cosmo Metals Limited released its Quarterly Activities and Appendix 5B Cash Flow Report for the quarter ended 31 March 2023.
- Significant exploration activities were undertaken at the Mt Venn Project in Western Australia, focusing on copper, nickel, and cobalt.
- Drilling at the Mt Venn prospect confirmed significant sulphide zones and a large mineralized system.
- A ground electromagnetic survey at the Eastern Mafic prospect identified new drill targets.
- Exploration and evaluation expenditures were reported for the quarter.
- The company disclosed its cash position at the end of the reporting period.
- Cosmo Metals maintains a focus on advancing exploration and technical programs while managing finances prudently.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| KKR Credit Income Fund (KKC) ORDINARY UNITS FULLY PAID |
Financials |
$661 |
Net Tangible Asset Backing
|
31 Jul 2025 9:06AM |
$2.370 |
$2.050 |
fallen by
13.50%
|
|
| Astron Corporation Limited (ATR) ORDINARY FULLY PAID |
Materials |
$245 |
Appendix 5B - Quarterly Cash Flows - 30 June 2025
|
31 Jul 2025 9:06AM |
$0.610 |
$0.580 |
fallen by
4.92%
|
|
ATR - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly cash flow report for the period ended 30 June 2025.
- Breakdown of operating, investing, and financing cash activities.
- Disclosures on receipts from customers and payments for exploration and evaluation.
- Details of payments to staff, administration, and corporate costs.
- Statement of cash at the beginning and end of the quarter.
- Details of related party payments and director remuneration.
- Narrative updates on exploration projects and corporate developments.
- Compliance statements with Australian Securities Exchange (ASX) requirements.
- Directors’ assertion of sufficient working capital for ongoing operations.
- Summary of future planned cash outflows and funding requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$276 |
Preliminary Final Results
|
31 Jul 2025 9:06AM |
$1.125 |
$0.875 |
fallen by
22.22%
|
|
AMH - Price-sensitive ASX Announcement
Full Release
Key Points
- AMCIL Limited reported its Preliminary Final Results for the year ended 30 June 2024.
- The company invests primarily in quality Australian listed securities with a long-term investment horizon.
- Portfolio returns and net asset value performance were discussed, highlighting key contributors and detractors.
- Dividend payments for shareholders were outlined, including franked dividends.
- The report described AMCIL's investment process, emphasizing quality, value, and sustainable returns.
- Market conditions and economic factors affecting investment performance were analyzed.
- Risk management strategies and portfolio diversification practices were outlined.
- The company provided commentary on portfolio changes and significant investment decisions during the period.
- AMCIL expressed an ongoing commitment to delivering sustainable capital and dividend growth.
- The outlook section addressed expectations for the upcoming financial year, referencing market uncertainties and opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurotech International Limited (NTI) ORDINARY FULLY PAID |
Health Care |
$14 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:06AM |
$0.022 |
$0.011 |
fallen by
50%
|
|
NTI - Price-sensitive ASX Announcement
Full Release
Key Points
- NTI reported progress in its clinical programs, especially targeting ASD with its NTI164 drug candidate.
- Positive clinical trial results reinforce the potential of NTI164 for pediatric neurological conditions.
- Further clinical trials, regulatory submissions, and commercialisation activities are planned.
- Financial report covers grant receipts, R&D tax incentives, operational costs, and quarter-end cash balance.
- Company remains focused on prudent cash management and achieving clinical development milestones.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Energy Resources of Australia Limited (ERA) ORDINARY FULLY PAID 'A' |
Energy |
$1,216 |
Appendix 4D and Half Year Report
|
31 Jul 2025 9:04AM |
$0.003 |
$0.003 |
risen by
20%
|
|
ERA - Price-sensitive ASX Announcement
Full Release
Key Points
- Report covers the half-year ended 30 June 2023.
- ERA recorded a loss after tax for the reporting period.
- Main operational focus remains the rehabilitation of the Ranger Project Area.
- Significant increase in estimated cost and timeframe for completing rehabilitation.
- Ongoing engagement with the Commonwealth Government, Traditional Owners, and other stakeholders.
- Requirement for additional funding to complete the rehabilitation project.
- Regulatory and approval risks continue to impact project delivery.
- Safety and environmental compliance remain key priorities.
- No production or sales of uranium oxide during the reporting period.
- Strategic review of rehabilitation execution and funding options is ongoing.
- Uncertainty regarding final cost and timing of project completion.
- Company is not currently in a position to declare dividends.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Po Valley Energy Limited (PVE) ORDINARY FULLY PAID |
Energy |
$76 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:04AM |
$0.059 |
$0.066 |
risen by
11.86%
|
|
PVE - Price-sensitive ASX Announcement
Full Release
Key Points
- Commencement of gas production at Podere Maiar-1 at the Selva Malvezzi production concession
- Completion and commissioning of infrastructure related to gas production
- Production and sales of natural gas commenced during the quarter
- Ongoing compliance with Italian regulatory authorities
- Cash outflows primarily related to development, production, and administration
- Company cash balance at end of quarter presented
- Strategic focus remains on maximizing value from core gas assets in northern Italy
- Discussion of the Italian energy market context and outlook
- Forward plans include further development activities and regulatory engagement
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Janus Electric Holdings Limited (JNS) ORDINARY FULLY PAID |
Utilities |
$22 |
Application for quotation of securities - JNS
|
31 Jul 2025 9:03AM |
$0.150 |
$0.220 |
risen by
46.67%
|
|
| Astron Corporation Limited (ATR) ORDINARY FULLY PAID |
Materials |
$245 |
Quarterly Activities Report - 30 June 2025
|
31 Jul 2025 9:03AM |
$0.610 |
$0.580 |
fallen by
4.92%
|
|
ATR - Price-sensitive ASX Announcement
Full Release
Key Points
- Progress reported on the Donald Mineral Sands Project, including development milestones.
- Exploration activities continued with updates on resource evaluation.
- Financial summary provided, including cash position and expenditure.
- Market conditions and project outlook discussed.
- Corporate governance and strategic initiatives updated for the quarter.
- Commentary on stakeholder engagement and regulatory compliance.
- Disclosure of key risks and mitigation strategies.
- Overview of planned activities for the next reporting period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Santa Fe Minerals Ltd (SFM) ORDINARY FULLY PAID |
Materials |
$47 |
Quarterly Activities and Cashflow Report
|
31 Jul 2025 9:03AM |
$0.265 |
$0.290 |
risen by
9.43%
|
|
SFM - Price-sensitive ASX Announcement
Full Release
Key Points
- Report covers the quarter ending 31 December 2023.
- Primary focus on gold exploration in Western Australia, particularly Youanmi and Carrick Projects.
- Geological mapping and soil sampling conducted to identify drilling targets.
- Field exploration at Carrick Project was delayed due to weather.
- Planning for future exploration activities is ongoing.
- Cash outflows detailed for exploration and administration.
- Company maintains a strong cash balance.
- SFM continues to review potential new project opportunities.
- Disciplined expenditure approach is being maintained.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$414 |
Update - Notification of buy-back - RG8
|
31 Jul 2025 9:03AM |
$2.060 |
$2.870 |
risen by
39.32%
|
|
| Turaco Gold Limited (TCG) ORDINARY FULLY PAID |
Materials |
$627 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:03AM |
$0.440 |
$0.595 |
risen by
35.23%
|
|
TCG - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant exploration and drilling activities at Eburnea and Boundiali Gold Projects in Côte d’Ivoire
- New gold discoveries and high-priority targets identified
- Strategic acquisition of 100% interest in Eburnea Gold Project
- Company remains well-funded with $7.3M cash at the end of the quarter
- Strong project pipeline with active exploration programs ongoing
- Focus on resource expansion and value creation in Côte d’Ivoire
- Appendix 5B cash flow report included, confirming solid financial position
- Board and management changes to strengthen leadership
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NeuroScientific Biopharmaceuticals Ltd (NSB) ORDINARY FULLY PAID |
Health Care |
$33 |
NeuroScientific Partners with Leading Biologic Manufacturer
|
31 Jul 2025 9:02AM |
$0.240 |
$0.100 |
fallen by
58.33%
|
|
Call 1300 880 160
Start a chat
Schedule a call
